The U.S. Food and Drug Administration (FDA) has approved expanded labeling for Epclusa®, a combination therapy for adults with chronic hepatitis C viral (HCV) infection.
This activity aims to enable the learner to apply knowledge of the benefits and applications of paper and electronic infusion logs.
This activity will cover the three major steps in normal hemostasis and the basics of treatment and management of patients with hemophilia.
The Nationwide Children’s Hospital Pediatric Hematology Division along with its affiliated institution, The Ohio State University College of Medicine, are jointly hosting an upcoming educational tr
The Partners in Bleeding Disorders Education Program recently relaunched “A School Nurses Guide to Bleeding Disorders: von Willebrand Disease.”
The Partners in Bleeding Disorders Education Program recently relaunched an educational activity focused on clinical research at hemophilia treatment centers (HTCs) entitled “The Basics of Research
The BloodCenter of Wisconsin (BCW) recently announced the launch of a new and more sensitive test for von Willebrand disease (VWD), a genetic disorder characterized by either a qualitative or quant
This new educational module designed to familiarize staff of the 140+ federally recognized US hemophilia treatment centers (HTCs) with the roles and responsibilities of the members of the HTC multidisciplinary team.
The two-and-a-half-day program provides hands-on training in musculoskeletal ultrasound.
A new educational module addresses the unique challenges facing individuals and families affected by inhibitors.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car